Role of lipoprotein apheresis in high-risk patients with cardiovascular diseases
Lipoprotein apheresis (LA) aims at removing atherogenic lipoproteins from the bloodstream: low-density lipoproteins (LDL), lipoprotein(a) (Lp(a)). In this way, the development of atherosclerotic plaques can be prevented (e. g. in patients with homozygous or heterozygous familial hypercholesterolemia) or the progression of atherosclerotic lesions can be stopped (within secondary prevention, after a cardiovascular event). In some patients, even a regression of plaques has been seen. As a result of non-progression or regression, no new cardiovascular events (CVE) occur. An effective reduction of CVE has been demonstrated in prospective studies, both in hypercholesterolemic patients and in patients with elevated Lp(a) levels [1] [2] [3] . In homozygous familial hypercholesterolemia LA treatment is life-saving 4 .
Before starting the extracorporeal therapy, all other therapeutic approaches have to be applied (optimal diet; statins, ezetimibe, bile acid sequestrants, Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors when tolerated). Other atherogenic risk factors -a positive family history for early CVE in first-degree relatives, hypertension, diabetes mellitus, obesity, renal insufficiency, smoking, low physical activity -contribute to the vascular risk.
In the 1960ies, a total plasma exchange was used to treat patients with homozygous familial hypercholesterolemia 5 . Later, more specific LA methods were developed 6 which avoid the major problem of total plasma exchange: all proteins are removed and replaced by either albumin or plasma from other people. Allergic reactions have been observed.
Different lipoprotein apheresis methods
LA methods are based on the following principles to remove atherogenic lipoproteins: • Filtration: The first filter separates plasma, the second filter retains big molecules (Lipidfiltration and MONET)
For details of the methods (devices, blood flow, treated volume, anticoagulation, adverse effects) see the literature 7, 8 . In general, LA therapy is rather expensive and laborious.
Some LA methods need a plasma separation as a first step, others work with whole blood.
Pleiotropic effects of lipoprotein apheresis
In addition to the effects on lipoproteins, all LA methods also exert other effects: Summary of results shown in our paper 10 This study included 75 patients (46 males, 29 females; mean age 62.6 years (range 29 -81 years); the majority of whom had been treated with LA for several years. We used 6 different LA methods (see Figure 1 ; marked with green flags). These methods differ with respect to underlying removal technique for lipoproteins and with respect to treated volume (plasma, whole-blood). Before and after one LA session additional blood was drawn in order to check protein concentrations. Usual lab methods to measure protein concentrations have been used. Because all LA methods need a saline infusion in order to return the extracorporeal plasma / blood to the patient, a hemodilution takes place. That is why all protein concentrations measured after LA sessions have been corrected for parallel changes in the hematocrit. Table 1 and Table 2 summarize the acute reduction rates of different proteins observed when using different LA methods.
Mechanisms underlying the removal of additional proteins
It was found that HELP and the filtration methods affect protein concentrations significantly more than the wholeblood LA methods.
The following mechanisms may explain the removal of additional proteins (besides lipoproteins):
Other proteins are also precipitated (HELP), cannot pass the second filter (Lipidfiltration and MONET), are adsorbed to the negatively charged surface (DALI and Liposorber D), are washed out of the columns with saline into the eluate when switching from one column to the other one (TheraSorb TM LDL) Abbreviations: HELP, heparin-induced extracorporeal LDL precipitation; TherLDL, TheraSorb TM LDL; LF, lipidfiltration; DALI, direct adsorption of lipoproteins; LipoD, Liposorber D; MONET, membrane filtration optimized novel extracorporeal treatment
The highest reductions were seen for fibrinogen (with HELP and filtration methods), for beta globulins (with all methods), and for ferritin (with filtration methods). With respect to removing apolipoprotein B-containing lipoproteins, the TheraSorb TM LDL system is the most specific one, additional proteins get lost to a much lower degree, similar to the whole-blood LA methods.
Consequences of effects of LA on serum protein levels

Rheological properties
The decrease of fibrinogen and of circulating lipoproteins improves the rheological properties of the blood. An increased perfusion has been measured in the heart following an LA session 11 . We had successfully treated patients with a diabetic foot syndrome who exhibited very high fibrinogen concentrations with the HELP system 12 .
Anticoagulation
The effect of LA methods on fibrinogen (especially with HELP and filtration methods) involves a certain danger of bleeding. HELP also has a definite impact on factors belonging to the prothrombin complex (II, VII, X) 13 . In patients taking an oral anticoagulant the HELP treatment IgA  IgM  IgG  HELP  -11  -12  -16  TherLDL  -13  -16  -19  DALI  -8  -16  -20  LF  -24  -45  -26  LipoD  -8  -12  -17  MONET  -23  -41  -19 Abbreviations: HELP, heparin-induced extracorporeal LDL precipitation; TherLDL, TheraSorb TM LDL; LF, lipidfiltration; DALI, direct adsorption of lipoproteins; LipoD, Liposorber D; MONET, membrane filtration optimized novel extracorporeal treatment; IgA, immunoglobulin A; IgM, immunoglobulin M; IgG, immunoglobulin G 
Edema
The decrease of albumin may contribute to the development of edema which is observed in some patients at the end of an LA session.
Iron deficiency
The reduction of ferritin and of transferrin may aggravate an iron deficit which is often seen in LA patients 14 .
Removal of pathogenic immunoglobulins
In particular, the filtration methods have been used to eliminate pathogenic antibodies 15 . Recently we treated a woman who suffered from a severe coronary heart disease, associated with rather high LDL-C levels and statin intolerance, and a concomitant myasthenia gravis. Sessions with MONET led to a relevant improvement of the clinical picture of the immunological disease and a significant reduction of the antibodies. Intravenous infusions of immunoglobulins could almost be stopped in this patient.
Infections because of low concentrations of immunoglobulins
We did not observe an increased frequency of infectious diseases among our LA patients. Though it makes sense to measure immunoglobulin concentrations in patients who are treated with filtration methods. In patients on MONET therapy, the pre-LA immunoglobulin M levels were below the normal range. At our center, we also perform immunoadsorption with columns with antibodies against immunoglobulins 16 . In these patients, we did not see infections.
Conclusions
The so-called "specific" LA methods also reduce other proteins besides lipoproteins. The amount of serum protein removal differs between LA methods used. HELP, using a precipitation, and the filtration methods (Lipidfiltration, MONET) exert more marked effects than the other LA methods. Rheological properties improve immediately after LA sessions. The removal of immunoglobulins may have beneficial consequences (with respect to eliminating pathogenic antibodies) but the immunoglobulin concentrations should be carefully monitored. Of course, when comparing with total plasma exchange, the main advantage of all LA methods is the fact that no proteins from somebody else have to be given. A total plasma exchange can be performed in patients with a chylomicronemia syndrome who suffer from an acute pancreatitis (one or two sessions needed). But this therapeutic approach should be avoided when treating high-risk patients over the years. An LA center should work with several LA methods -thus offering the opportunity to switch to another method in patients who show an insufficient lipid-lowering efficiency or who suffer from adverse effects 9 .
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